Trial intelligence / Profile preview

Clinical trial evaluating adipokines as pharmacological targets to prevent vascular aging in prediabetes

2018-000650-21Phase 4Active

Sponsor
Universidad Autónoma de Madrid
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metformin in prediabetes (2 arms), sponsored by Universidad Autónoma de Madrid. Primary endpoints: Validation of adipokines as endothelial dysfunction biomarkers and Evolution of hyperglycemia parameters. Started Aug 2018; status: active.

02

Drugs

metformin
03

Conditions

prediabetes

Beyond the preview

Go deeper on 2018-000650-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000650-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call